- Home
- PRLD vs CNTY Comparison
PRLD vs CNTY Comparison
Compare PRLD & CNTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRLD
- CNTY
- Stock Information
- Founded
- PRLD 2016
- CNTY 1992
- Country
- PRLD United States
- CNTY United States
- Employees
- PRLD N/A
- CNTY N/A
- Industry
- PRLD Medicinal Chemicals and Botanical Products
- CNTY Hotels/Resorts
- Sector
- PRLD Health Care
- CNTY Consumer Discretionary
- Exchange
- PRLD Nasdaq
- CNTY Nasdaq
- Market Cap
- PRLD 50.1M
- CNTY 46.3M
- IPO Year
- PRLD 2020
- CNTY 1993
- Fundamental
- Price
- PRLD $0.78
- CNTY $1.50
- Analyst Decision
- PRLD Strong Buy
- CNTY Strong Buy
- Analyst Count
- PRLD 2
- CNTY 6
- Target Price
- PRLD $4.50
- CNTY $5.17
- AVG Volume (30 Days)
- PRLD 110.2K
- CNTY 94.4K
- Earning Date
- PRLD 05-06-2025
- CNTY 05-12-2025
- Dividend Yield
- PRLD N/A
- CNTY N/A
- EPS Growth
- PRLD N/A
- CNTY N/A
- EPS
- PRLD N/A
- CNTY N/A
- Revenue
- PRLD $7,000,000.00
- CNTY $575,919,000.00
- Revenue This Year
- PRLD N/A
- CNTY $8.17
- Revenue Next Year
- PRLD N/A
- CNTY $4.43
- P/E Ratio
- PRLD N/A
- CNTY N/A
- Revenue Growth
- PRLD N/A
- CNTY 4.67
- 52 Week Low
- PRLD $0.61
- CNTY $1.30
- 52 Week High
- PRLD $6.80
- CNTY $5.09
- Technical
- Relative Strength Index (RSI)
- PRLD 46.96
- CNTY 49.43
- Support Level
- PRLD $0.73
- CNTY $1.41
- Resistance Level
- PRLD $1.00
- CNTY $1.55
- Average True Range (ATR)
- PRLD 0.09
- CNTY 0.07
- MACD
- PRLD -0.01
- CNTY 0.05
- Stochastic Oscillator
- PRLD 18.96
- CNTY 80.00
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.
About CNTY Century Casinos Inc.
Century Casinos Inc is a casino entertainment company that develops and operates gaming establishments as well as related lodging, restaurants, horse racing (including off-track betting), and entertainment facilities in North America. The company has three reportable segments based on the geographical locations in which its casinos operate; United States; Century Casino & Hotel-Central City, and Century Casino & Hotel-Cripple Creek in Colorado, Mountaineer Casino, Racetrack & Resort in West Virginia, and Century Casino Caruthersville, and Century Casino Cape Girardeau in Missouri, Canada; Century Casino & Hotel, Century Casino St. Albert, Century Mile Racetrack in Edmonton and Casino Century Downs Racetrack and Casino in Calgary, and Poland; Casinos Poland.